Y10S 930/18
Thymus derived hormone or factor
Official title: Thymus derived hormone or factor; related peptides
Y10S930/18 (Thymus derived hormone or factor) appears on 64 US grants and 9 published applications in this corpus.
Search patents in Y10S- Granted patents
- 64
- Published applications
- 9
- Assignees
- 28
- Inventors
- 91
- Latest grant
- 27 Mar 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 4 | 0 |
| 1979 | 4 | 0 |
| 1980 | 4 | 0 |
| 1981 | 5 | 0 |
| 1982 | 5 | 0 |
| 1983 | 9 | 0 |
| 1984 | 8 | 0 |
| 1985 | 6 | 0 |
| 1986 | 4 | 0 |
| 1987 | 8 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Treatment of skin, and wound repair, with thymosin beta 427 Mar 2012US 8,143,218 B2Regenerx Biopharmaceuticals, Inc.
- Thymosin β4 compositions11 Sep 2007US 7,268,118 B2United States of America as represented by The Secretary of Health
- Synthetic, statistic thymic peptide combination and its use as a preparation with immunological and/or endocrinological effect1 Oct 2002US 6,458,761 B2
- Solid phase process for synthesizing peptides8 Aug 1989US 4,855,407 AAlpha-1 Biomedicals, Inc.
- Treatment of allergy with thymopentin7 Jun 1988US 4,749,690 AOrtho Pharmaceutical Corporation
- Thymosin Beta 4 Promotes Wound Repair16 Nov 2017US 2017/0326207 A1Regenerx Biopharmaceuticals, Inc.
- Thymosin beta 4 promotes wound repair26 May 2011US 2011/0124550 A1Regenerx Biopharmaceuticals, Inc.
- Thymosin beta 4 compositions and methods22 Jan 2009US 2009/0023663 A1U.S.A. as represented by the Secretary of Health Office of Technology Transfer
- Compositions and methods for promoting wound healing and tissue repair17 May 2007US 2007/0111931 A9
- Treatment of skin, and wound repair, with thymosin beta 411 Jan 2007US 2007/0009469 A1United States of America as represented by The Secretary of Health Office of Technology Transfer
Most cited
By later US patents
- Microencapsulation of water soluble active polypeptides483US 4,675,189 ASyntex (U.S.A.) Inc. · 1987
- Polypeptides/chelating agent nasal compositions having enhanced peptide absorption175US 4,476,116 ASyntex (U.S.A.) Inc. · 1984
- Thymosin alpha 157US 4,079,127 ABoard of Regents, The University of Texas · 1978
- Nonapeptides49US 4,229,438 ATakeda Chemical Industries, Ltd. · 1980
- Synthesis of thymosin .alpha..sub.146US 4,148,788 AHoffmann-La Roche Inc. · 1979